Literature DB >> 16596119

Identification of cis- and trans-acting factors possibly modifying the risk of epimutations on chromosome 15.

Corinna Zogel1, Stefan Böhringer, Stephanie Gross, Raymonda Varon, Karin Buiting, Bernhard Horsthemke.   

Abstract

In the majority of patients with a chromosome 15 imprinting defect (ID) causing Prader-Willi syndrome (PWS) or Angelman syndrome (AS), the defect is a primary epimutation that occurred spontaneously in the absence of a DNA mutation. We have investigated whether common DNA sequence variants in the bipartite imprinting centre (IC) are associated with an increased susceptibility to imprinting defects. We have determined the haplotype structure of the IC and found that the two IC elements called 'PWS-SRO' and 'AS-SRO' lie on separate haplotype blocks. To identify susceptible IC sequence variants, we have used the transmission disequilibrium test. While we did not observe preferential transmission of a paternal allele or haplotype in 41 PWS-ID trios, we found a trend for preferential maternal transmission of one AS-SRO haplotype (H-AS3) in 48 AS-ID trios (P=0.058) and could identify two sequence variants in H-AS3 that are responsible for this effect. We also obtained tentative evidence that homozygosity for the 677C>T variant of the 5,10-methylenetetrahydrofolate reductase (MTHFR) gene on chromosome 1 might increase the risk of a maternal imprinting defect: the frequency of the TT genotype was significantly higher in the mothers of the AS patients with an imprinting defect than in the patients' fathers or the general population (P=0.028). Our findings suggest that women with the IC haplotype H-AS3 or homozygosity for the MTHFR 677C>T variant may have an increased risk of conceiving a child with an imprinting defect, although the absolute risk is low.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16596119     DOI: 10.1038/sj.ejhg.5201602

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  9 in total

1.  Intra- and interindividual epigenetic variation in human germ cells.

Authors:  James M Flanagan; Violeta Popendikyte; Natalija Pozdniakovaite; Martha Sobolev; Abbas Assadzadeh; Axel Schumacher; Masood Zangeneh; Lynette Lau; Carl Virtanen; Sun-Chong Wang; Arturas Petronis
Journal:  Am J Hum Genet       Date:  2006-05-25       Impact factor: 11.025

2.  The C15orf2 gene in the Prader-Willi syndrome region is subject to genomic imprinting and positive selection.

Authors:  Michaela Wawrzik; Unga Arifa Unmehopa; Dick Frans Swaab; Johannes van de Nes; Karin Buiting; Bernhard Horsthemke
Journal:  Neurogenetics       Date:  2009-12-19       Impact factor: 2.660

3.  Angelman syndrome imprinting center encodes a transcriptional promoter.

Authors:  Michael W Lewis; Jason O Brant; Joseph M Kramer; James I Moss; Thomas P Yang; Peter J Hansen; R Stan Williams; James L Resnick
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-05       Impact factor: 11.205

Review 4.  Evolution in health and medicine Sackler colloquium: Comparative genomics of autism and schizophrenia.

Authors:  Bernard Crespi; Philip Stead; Michael Elliot
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-01       Impact factor: 11.205

5.  Semen samples showing an increased rate of spermatozoa with imprinting errors have a negligible effect in the outcome of assisted reproduction techniques.

Authors:  Cristina Camprubí; Marta Pladevall; Mark Grossmann; Nicolás Garrido; Maria Carme Pons; Joan Blanco
Journal:  Epigenetics       Date:  2012-08-13       Impact factor: 4.528

6.  Protein-binding elements establish in the oocyte the primary imprint of the Prader-Willi/Angelman syndromes domain.

Authors:  Yotam Kaufman; Maya Heled; Jonathan Perk; Aharon Razin; Ruth Shemer
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-08       Impact factor: 11.205

7.  Transcription is required to establish maternal imprinting at the Prader-Willi syndrome and Angelman syndrome locus.

Authors:  Emily Y Smith; Christopher R Futtner; Stormy J Chamberlain; Karen A Johnstone; James L Resnick
Journal:  PLoS Genet       Date:  2011-12-29       Impact factor: 5.917

8.  Update of the EMQN/ACGS best practice guidelines for molecular analysis of Prader-Willi and Angelman syndromes.

Authors:  Jasmin Beygo; Karin Buiting; Simon C Ramsden; Rachael Ellis; Jill Clayton-Smith; Deniz Kanber
Journal:  Eur J Hum Genet       Date:  2019-06-24       Impact factor: 4.246

9.  Pharmacodynamic Gene Testing in Prader-Willi Syndrome.

Authors:  Janice Forster; Jessica Duis; Merlin G Butler
Journal:  Front Genet       Date:  2020-11-20       Impact factor: 4.599

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.